The Chem Ledger
The Chem Ledger #43: Rare earth magnets in Estonia, obesity drug manufacturing in Texas
Plus: Pfizer's Metsera acquisition, silicon anodes in Washington, and Lanxess's polymer divestment
The Chem Ledger
Plus: Pfizer's Metsera acquisition, silicon anodes in Washington, and Lanxess's polymer divestment
The Chem Ledger
Tiny Tech, Vast Ambitions
The Chem Ledger
Plus, Medtronic's FDA approval for Parkinson's device, Thermo Fisher Scientific's $4.1B acquisition of purification deal & more.